• Quercetin Workflows for PI3K and Ferroptosis

  2026-09-18

  Build more informative Quercetin experiments by pairing PI3K and apoptosis readouts with ferroptosis, lipid, and mitochondrial assays. This workflow guide translates a new Wilson’s disease study into practical cancer research and liver-injury assay designs while emphasizing solvent control, timing, and mechanism validation.

• DRB: From Pol II Elongation to RNA Translation

  2026-09-18

  5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) is more than a transcriptional inhibitor: it is a practical perturbation tool for connecting CDK-dependent RNA polymerase II control with RNA stability, translation, and cell-state decisions. This thought-leadership analysis outlines how to use DRB rigorously while avoiding overinterpretation of a biologically broad mechanism.

• Roscovitine: A Practical CDK Assay Strategy

  2026-09-17

  Roscovitine, also known as Seliciclib or CYC202, is more than a CDK2 tool: its multi-CDK profile requires careful assay design. This guide connects kinase selectivity, reversible late-prophase arrest, and chemoinformatics-informed compound selection for stronger cancer biology research.

• Simvastatin (Zocor): Cell Assay Workflows

  2026-09-17

  Build more reproducible Simvastatin experiments by separating cholesterol-pathway effects from solvent, prodrug, and stress responses. This practical guide connects hepatic cancer, lipid-metabolism, endothelial, and stress-aware assay designs with executable preparation and troubleshooting steps.

• PLGA Nano-Adjuvant Enhances Mucosal Immunity in Chicks

  2026-09-16

  This study develops PEI-LSP-RA-PLGA, a layered PLGA nanoparticle adjuvant designed to combine sustained antigen-associated delivery with intestinal targeting. In chicks receiving an inactivated H9N2 vaccine, the formulation enhanced systemic IgG, intestinal IgA, immune-organ activity, and T-cell responses while implicating CCR9/CCR6 chemokine signaling and mucosal immune pathways.

• Modeling Gut Neuro-Epithelial Connections

  2026-09-16

  This reference study introduces a two-compartment microfluidic device that positions human intestinal epithelial cells and mouse enteric neurons in adjacent, connected chambers. The platform preserves epithelial organization while enabling direct observation of neuronal projections, epithelial contact, and epithelial regulation of enteric neurite growth.

• Spermine as a Membrane-State Assay Tool

  2026-09-15

  Spermine is an endogenous polyamine that links ion channel regulation with rigorous cellular metabolism research. This article develops a compartment-aware assay strategy inspired by CLCC1 studies while clearly separating established channel pharmacology from exploratory nuclear egress hypotheses.

• Machine Learning for Cross-Cell-Line MoA Prediction

  2026-09-15

  Warchal, Dawson, and Carragher evaluated whether machine-learning models trained on high-content cellular phenotypes can predict compound mechanism of action across genetically and morphologically distinct breast cancer cell lines. Their results show that convolutional neural networks perform comparably to ensemble tree models within a cell line, but transfer less effectively to an unseen line, highlighting the importance of cell-line-aware validation.

• Molidustat: Designing Better HIF Assays

  2026-09-14

  Molidustat (BAY85-3934) links HIF-PH inhibition with erythropoietin stimulation in chronic kidney disease anemia. This assay-centered guide shows how to distinguish direct oxygen-sensing effects from downstream VHL-mediated HIF-1α turnover.

• PF-562271 HCl: FAK/Pyk2 Workflow Guide

  2026-09-14

  Build sharper cancer research assays with PF-562271 HCl by pairing reversible FAK/Pyk2 inhibition with phospho-signaling, viability, adhesion, and migration readouts. The workflow emphasizes dose timing, selectivity controls, and data-driven compound-panel design rather than relying on a single endpoint.

• F9 Regulates Senescence After CDK4/6 Inhibition

  2026-09-13

  A genome-wide CRISPR/Cas9 screen identified coagulation factor IX (F9) as a regulator of the senescence-like response triggered by Palbociclib in breast cancer cells. Genetic loss of F9 weakened proliferation arrest, whereas recombinant F9 promoted arrest, providing a mechanistic entry point for understanding variable responses to CDK4/6 inhibition.

• LINC01977 Super-Enhancer Hijacking in Early LUAD

  2026-09-12

  Zhang et al. identify LINC01977 as a super-enhancer-hijacked lncRNA that reinforces canonical TGF-β/SMAD3 signaling and promotes early-stage lung adenocarcinoma malignancy. The study links tumor-associated macrophage signaling, enhancer architecture, SMAD3 trafficking, and CBP/P300-dependent transcription, providing a mechanistic framework for future lung adenocarcinoma research.

• MG-262 Proteasome Inhibition: Practical Workflows

  2026-09-11

  MG-262 enables reversible, cell-permeable control of proteasome chymotryptic activity for mechanistic studies of ubiquitin signaling, apoptosis, and inflammatory epithelial biology. This guide connects assay design with the BIRC2/BIRC3 findings reported in pulmonary epithelial cells and provides practical optimization and troubleshooting strategies.

• HBV Capsid Purification and Phosphorylation Profiling

  2026-09-11

  A 2026 STAR Protocols study presents an integrated workflow for isolating recombinant hepatitis B virus capsids from HepG2 cells and comparing their phosphorylation states by phosphate-affinity SDS-PAGE. Its main contribution is the combination of sucrose-gradient purification, structural validation, and semi-quantitative mobility profiling to evaluate global capsid phosphorylation across preparations.

• EZ Cap Cy5 Firefly Luciferase mRNA Workflow

  2026-09-10

  Use one mRNA to separate delivery, intracellular trafficking, and translation with Cy5 fluorescence plus Firefly luciferase output. This practical workflow supports transfection optimization, translation efficiency assays, and in vivo bioluminescence imaging while highlighting limitations when reporter data are translated to therapeutic mRNA studies.

8043 records 1/537 page Next 12345 下5页 Last page